Previous
Previous

An open label N of 1 study to evaluate the safety and efficacy of long-term treatment with Ivacaftor in combination with ATALUREN (PTC124) in Subjects with Nonsense Mutation Cystic Fibrosis

Next
Next

Mouse models of Fibrous Dysplasia (FD) as a tool for developing rational and effective therapies